Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual DiseaseE. Benedetti, Sara Galimberti, Fabrizio Mavilia et al.|Journal of Clinical Medicine|2023Cited by 1